Smallpox revaccination of 21 000 first responders in Israel: lessons learned

International Journal of Infectious Diseases

Volumn 13, Issue 3, 2009, Pages 403-409

  Anis, Emilia ^a,b   Leventhal, Alex ^a,b   Slater, Paul E ^a,b   Shinar, Eilat ^c   Yahalom, Vered ^c   Smetana, Zahava ^a   Zach, Ruth ^a   Reznikovich, Shmuel ^a   Mendelson, Ella ^a   Danon, Yehuda ^a,d   Lev, Boaz ^a  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c MAGEN DAVID ADOM   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Serologic response; Side effects; Smallpox revaccination; Vaccine take; VIG production

Indexed keywords

SMALLPOX VACCINE; VACCINIA ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTHRALGIA; ARTICLE; AXILLARY LYMPH NODE; AXILLARY PAIN; CELLULITIS; CERVICAL LYMPHADENOPATHY; CHILD; CHILL; CONTROLLED STUDY; ERYTHEMA MULTIFORME; ETHNICITY; FATIGUE; FEMALE; FEVER; HEADACHE; HEALTH PROGRAM; HERPES ZOSTER; HUMAN; INJECTION SITE PAIN; INJECTION SITE SWELLING; ISRAEL; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; OPTIC NEURITIS; PAIN; PARESTHESIA; PERIOMYOCARDITIS; PRURITUS; PUSTULE; RETINA VEIN OCCLUSION; REVACCINATION; SEROLOGY; SIDE EFFECT; SMALLPOX; URTICARIA; VACCINIA; VIRUS STRAIN; WEAKNESS; COHORT ANALYSIS; HEALTH CARE PERSONNEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS IMMUNIZATION; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; ISRAEL; MALE; MASS IMMUNIZATION; MIDDLE AGED; SMALLPOX VACCINE; YOUNG ADULT;

EID: 64649099315     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.08.007     Document Type: Article

References (14)

1. Gerichter C.H. Preparation of vaccine against smallpox in chorioallantoic membranes of chicken embryos (1966), Public Health Services, Israeli Ministry of Health, Jerusalem, Israel p. 36-41
2. Rotz LD, Dotson DA, Damon IK, Becher JA; Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001;50(RR-10):1-25.
3. Centers for Disease Control and Prevention (CDC). Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003;52:282-4 and 52(RR-7):1-16.
4. Somekh E., Smetana Z., Tanay A., Dalal I., Babai I., and Mendelson E. Determination of immunity to vaccinia virus using diluted, inactivated vaccinia vaccine solution for skin testing. Vaccine 23 (2004) 321-324
5. Gerichter C.H., Borusch D., and Silberstein W. Some biological and technical aspects of smallpox vaccination (1966), Public Health Services, Israeli Ministry of Health, Jerusalem, Israel p. 30-35
6. Frey S.E., Newman F.K., Yan L., and Belsche R.B. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289 (2003) 3295-3299
7. Grabenstein J.D., and Winkenwerder Jr. W. US military smallpox vaccination program experience. JAMA 289 (2003) 3278-3282
8. Balicer R., Davidovitch N., Huerta M., Cohen D., and Grotto I. Smallpox vaccination techniques: considerations and unresolved issues. Harefuah 144 (2005) 51-56 69
9. Balicer R., Grotto I., Huerta M., Leventhal A., Zach R., Yahalom V., et al. Beveled needle technique is not associated with low 'take' rates in Israeli smallpox revaccination campaign. Human Vaccines 1 (2005) 224-227
10. Frey S.E., Couch R.B., Tacket C.O., Treanor J.J., Wolff M., Newman F.K., et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 346 (2002) 1265-1274
11. Couch R.B., Winokur P., Edwards K.M., Black S., Atmar R.L., Stapleton J.T., et al. Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses. J Infect Dis 195 (2007) 826-832
12. Nishiura H., Schwehm M., and Eichner M. Still protected against smallpox? Estimation of the duration of vaccine-induced immunity against smallpox. Epidemiology 17 (2006) 576-581
13. Nishiura H., and Eichner M. Estimation of the duration of vaccine induced residual protection against severe and fatal smallpox based on secondary vaccination failure. Infection 34 (2006) 241-246
14. Orr N., Forman M., Marcus H., Lustig S., Paran N., Grotto I., et al. Clinical and immune responses after revaccination of Israeli adults with the Lister strain of vaccinia virus. J Infect Dis 190 (2004) 1295-1302